$HGEN @Humanigen is in the middle of Phase 3 Trials for their Covid Therapeutic #Lenzilumab. The Compassionate Use Data was Outstanding from the Mayo Clinic! When will the market wake up to this?  $PFE $GILD $MRNA @CNBC  https://t.co/sOufrivDs6 https://t.co/KAiDTv7ROT